Stay updated on Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial

Sign up to get notified when there's something new on the Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The footer release label updates from v3.8.0 to v3.8.1, with no change to the study record history.
    Difference
    0.1%
    Check dated 2026-11-22T15:03:21.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    No Change Detected
  4. Check
    21 days ago
    Change Detected
    Summary
    The footer now displays website revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-01T15:52:53.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    A site-wide NIH announcement has been added above the study record, describing a transition from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    0.5%
    Check dated 2026-10-25T16:52:22.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T19:00:07.000Z thumbnail image
  7. Check
    42 days ago
    Change Detected
    Summary
    The site footer now displays release revision v3.7.1 instead of v3.7.0; the study record content is unchanged.
    Difference
    0.1%
    Check dated 2026-10-11T19:45:01.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    A new revision entry, v3.7.0, was added to the Record History and the previous v3.6.6 entry was removed. This reflects an update to the page's version history.
    Difference
    0.1%
    Check dated 2026-09-20T20:41:54.000Z thumbnail image

Stay in the know with updates to Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial page.